Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Legend Biotech Corp (NASDAQ: LEGN) CEO Huang Ying executed a transaction involving the sale of 5,566 ordinary shares on June 25, 2026. The sale, valued at $82,265, was conducted to cover withholding tax obligations resulting from the vesting of restricted share units. Following this activity, Huang Ying retains direct ownership of 241,872 ordinary …
Anthony Bergmann, serving as the Chief Financial Officer for Capricor Therapeutics, Inc., executed a significant divestment of company equity on June 25, 2026. The transaction involved the sale of 24,100 shares of common stock, generating a total proceeds value of $732,158. This sale was facilitated through a Rule 10b5-1 trading plan established in…
Karen Krasney, Executive Vice President and General Counsel at Capricor Therapeutics, reported the sale of 24,100 shares totaling $732,158 on June 25, 2026, following the exercise of stock options. The transaction was executed under a 10b5-1 trading plan established in December 2025, with shares sold at prices ranging from $30.00 to $30.88. This ac…
Insight Holdings Group, LLC, along with its affiliated investment vehicles, executed a significant divestment of Hinge Health, Inc. Class A Common Stock, totaling approximately $121.5 million. The transaction involved the sale of 1,466,667 shares on June 29, 2026, following a prior conversion of Class B shares into Class A shares. This sale was con…
Insight Holdings Group, LLC and its affiliated investment funds executed a significant divestment of 530,982 Class A Common Stock shares in Hinge Health, Inc. (NASDAQ:HNGE) on June 25, 2026. The transactions, totaling approximately $38.1 million, were facilitated through the conversion of an equivalent number of Class B shares and executed under a …
CrowdStrike Holdings CEO George Kurtz sold 1,720 shares of Class A common stock for $1.19 million on June 26, 2026, as part of a pre-arranged 10b5-1 trading plan adopted in January 2026. The sale price ranged from $690.96 to $703.56 per share, with the stock currently trading at $742.56, up 58% over the past six months. Following the transaction, K…
Entities linked to Nicholas S. Schorsch, a significant 10% shareholder in American Strategic Investment Co. (NASDAQ: NYC), have executed recent purchases of the company's Class A common stock. These transactions, totaling $54,740, took place between June 25 and June 29, 2026. The acquisitions occurred during a period when the stock price increased …
George Kurtz, the President and Chief Executive Officer of CrowdStrike Holdings, Inc. (NASDAQ: CRWD), has executed a series of sales involving Class A common stock, totaling approximately $2.23 million. These transactions occurred on June 25 and June 26, 2026, and were conducted under the framework of a Rule 10b5-1 trading plan established earlier …
NextNav Inc. (NASDAQ: NN) Chief Accounting Officer Shams Sammaad executed a transaction on June 29, 2026, selling 2,006 shares of common stock. The sale, processed through a pre-arranged Rule 10b5-1 plan established on March 30, 2026, generated proceeds totaling $35,777. These funds are designated to satisfy tax withholding obligations associated w…
James William Rogers, Chief Financial Officer of Tempus AI, Inc. (TEM), executed a significant transaction involving the sale of 11,529 shares of the company's Class A Common Stock on June 25, 2026. The transaction, valued at $634,095, was processed at an average price of $55.00 per share. This divestment was conducted in accordance with a Rule 10b…
Jennifer Doudna, a director at Tempus AI, Inc. (NASDAQ: TEM), recently executed a sale of 2,673 shares of Class A Common Stock under a pre-existing Rule 10b5-1 trading plan. The transaction, valued at approximately $147,015, occurred as the company navigates a period of stock price appreciation and expands its healthcare technology partnerships.
Marsida Saraci, Alphabet Inc.'s Vice President and Chief Accounting Officer, executed a sale of 449 shares of Class C capital stock on June 26, 2026, totaling approximately $153,432. The transaction, facilitated through a pre-established Rule 10b5-1 trading plan adopted in May 2025, occurred as Alphabet's shares traded between $341.72 and $342.72. …
Glenbrook Capital Management, acting as investment manager for a ten percent shareholder account in SenesTech Inc. (NASDAQ: SNES), executed a series of open market purchases totaling $39,102 across four trading days in late June 2026. The acquisition of 25,416 shares occurred at prices between $1.5244 and $1.5558, positioning the fund near the stoc…
Nick Rosenberg, Executive Vice President at Metropolitan Bank Holding Corp. (NASDAQ: MCB), executed two separate sales of company common stock this week, totaling 353 shares for approximately $35,308. These transactions, conducted under a Rule 10b5-1 trading plan established in June 2025, occurred at prices near the stock's 52-week high of $100. Th…
Tang Capital Management LLC and its manager, Kevin Tang, have significantly increased their ownership in Boundless Bio (NASDAQ:BOLD) through a series of recent transactions. Between June 25 and June 29, 2026, the group acquired an additional 286,333 shares, bringing their total indirect holdings to 2,533,845 shares. This insider activity occurs as …
Adaptive Biotechnologies Corp (NASDAQ:ADPT) Director Michelle Renee Griffin executed a sale of 52,084 common shares on June 25, 2026, valued at approximately $1,051,055. The transactions occurred under a Rule 10b5-1 trading plan established in November 2025, with shares sold at a weighted-average price of $20.18, reflecting a range between $20.00 a…
Michael A. DeGiglio, Chief Executive Officer of Village Farms International, Inc. (NASDAQ:VFF), has increased his personal stake in the company through recent open market purchases. The transactions occur against a backdrop of significant stock price fluctuation and concurrent operational developments, including greenhouse expansion in British Colu…
Mark Brazeal, Broadcom's Chief Legal & Corporate Affairs Officer, executed a significant stock sale on June 25, 2026, divesting 25,000 shares valued at $9.675 million. The transaction, disclosed via SEC Form 4, reduces his direct holdings to 244,989 shares. Concurrently, Broadcom is advancing its financial strategy through a $2.5 billion debt tende…
Bethany Mayer, a director at Box Inc. (NASDAQ: BOX), executed a series of share sales totaling $105,561 on June 26, 2026. The transactions were conducted under a Rule 10b5-1 trading plan established on September 22, 2025. This sale took place as Box Inc. shares appreciated by over 9% in the preceding week, reaching a trading price of $26.57. The co…
Luke Evnin, a director at Werewolf Therapeutics, Inc. (NASDAQ: HOWL), executed a sale of 157,084 shares of the company's common stock on June 29, 2026. The transaction, valued at $47,125, was carried out through a Rule 10b5-1 trading plan established on March 26, 2026. The shares were sold at a weighted average price of $0.30 per share, with indivi…
Box Inc. (NYSE:BOX) Chief Operating Officer Olivia Nottebohm executed a sale of 5,834 Class A common shares on June 25, 2026, realizing $145,674. The transaction, governed by a Rule 10b5-1 plan established in July 2025, stands in contrast to recent positive fundamental developments, including first-quarter fiscal 2027 earnings that beat consensus a…
Michael George Rosenbaum, Chief Executive Officer of Guidewire Software, Inc. (NASDAQ:GWRE), executed a stock sale on June 29, 2026, as documented in a recent regulatory filing. The transaction involved the liquidation of 1,200 shares at $124.29 per share, totaling $149,148. This sale was facilitated through an automated 10b5-1 trading plan establi…
Northwest Natural Holding Co (NASDAQ: NWN) director David Anderson has completed a stock sale as part of a pre-arranged trading plan established before his retirement from the chief executive role. The transaction occurs against a backdrop of recent quarterly earnings results that presented a mixed picture for the utility company, alongside diverge…
Jeffrey E. Eberwein, Chief Executive Officer and Director of Star Equity Holdings, Inc. (NASDAQ: STRR), has executed two separate transactions to acquire 10,000 shares of the company's common stock, totaling $110,100. The purchases occurred on June 25 and June 29, 2026, at a consistent price of $11.01 per share. Following these acquisitions, Eberwe…
Bakkt Holdings Inc. (NASDAQ:BKKT) Chief Accounting Officer Joseph Sean-Walsh Henderson executed a stock sale on June 25, 2026, to settle tax liabilities stemming from restricted stock unit vesting. This transaction occurs against a backdrop of significant corporate restructuring, including the divestiture of the company's loyalty business and a str…
